Drawing for Q QUINTILES

USPTO serial 77236902

Q QUINTILES

Reviewed by CopyMark Law Group

Reg. 3565435Status 710
Filing date
Status date
Registration date
Jan 20, 2009
Examiner
BEN, LINDSEY HEATHER
Law office
TMEG LAW OFFICE 108

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Q QUINTILES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

ARLENE D. HANKS Moore & Van Allen PLLC3015 Carrington Mill BoulevardSuite 400Morrisville, NC 27560

Goods and services

ClassDescriptionStatusFirst use
035Computerized database management and data processing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; marketing services for others, namely, creating and managing product sales and product launch programs in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business marketing consulting services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; market research and analysis services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; personnel recruitment and placement; providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologicsSECTION 8 - CANCELLEDJul 28, 1998
041Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewithSECTION 8 - CANCELLED
042Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for othersSECTION 8 - CANCELLEDJul 28, 1998
044Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, developing and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medical and pharmaceuticalsSECTION 8 - CANCELLEDJul 28, 1998
045Regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugs, devices and biologicsSECTION 8 - CANCELLEDJul 28, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 23, 2019CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jan 20, 2018REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 19, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 12, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 27, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 27, 2015NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 27, 2015C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 27, 2015A7OKAMENDMENT UNDER SECTION 7 - PROCESSED
Jan 21, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 16, 2015ES7RTEAS SECTION 7 REQUEST RECEIVED
Jan 16, 2015E815TEAS SECTION 8 & 15 RECEIVED
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 22, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 20, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 18, 2008REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 17, 2008CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 26, 2008SUPCSTATEMENT OF USE PROCESSING COMPLETE
Nov 26, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 20, 2008IUAFUSE AMENDMENT FILED
Nov 20, 2008EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 10, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 18, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2008NPUBNOTICE OF PUBLICATION
Feb 13, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2008ALIEASSIGNED TO LIE
Jan 14, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2007XAECEXAMINER'S AMENDMENT ENTERED
Oct 19, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 19, 2007GNEAEXAMINERS AMENDMENT E-MAILED
Oct 19, 2007CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 17, 2007DOCKASSIGNED TO EXAMINER
Jul 27, 2007NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance